Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,356,079
+$56,388 QoQ
Shares Held
9,277
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#2,214
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dorato Capital Management holds $7,744,941 across 10 Drug Manufacturers - General names. JNJ ranks #1 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
9,277 | $2,356,079 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,370 | $2,103,545 | |
| 3 | AMGN |
Amgen Inc
|
4,861 | $1,760,265 | |
| 4 | ABBV |
AbbVie Inc.
|
4,149 | $1,044,054 | |
| 5 | NVS |
Novartis AG
|
2,104 | $329,738 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
565 | $71,382 | |
| 7 | LLY |
ELI LILLY & Co
|
34 | $40,780 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,356,079 | 9,277 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $2,299,691 | 9,408 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,946,985 | 9,408 | Shares | Sole | 2026-01-16 | |
| No filing history on record for this holder in this stock. | ||||||